000 01617 a2200433 4500
005 20250517042719.0
264 0 _c20151215
008 201512s 0 0 eng d
022 _a1573-7276
024 7 _a10.1007/s10585-015-9734-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDecio, Alessandra
245 0 0 _aCediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.
_h[electronic resource]
260 _bClinical & experimental metastasis
_cOct 2015
300 _a647-58 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aCisplatin
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aOvarian Neoplasms
_xpathology
650 0 4 _aPaclitaxel
_xpharmacology
650 0 4 _aQuinazolines
_xpharmacology
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aCesca, Marta
700 1 _aBizzaro, Francesca
700 1 _aPorcu, Luca
700 1 _aBettolini, Rossana
700 1 _aUbezio, Paolo
700 1 _aTaraboletti, Giulia
700 1 _aBelotti, Dorina
700 1 _aGiavazzi, Raffaella
773 0 _tClinical & experimental metastasis
_gvol. 32
_gno. 7
_gp. 647-58
856 4 0 _uhttps://doi.org/10.1007/s10585-015-9734-1
_zAvailable from publisher's website
999 _c25084142
_d25084142